scholarly journals Secondary Prevention of Cardiovascular Diseases and Application of Technology for Early Diagnosis

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Sachith Paramie Karunathilake ◽  
Gamage Upeksha Ganegoda
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Cardiovascular Diseases ◽  
High Risk ◽  
Secondary Prevention ◽  
Disease Prediction ◽  
Preventive Healthcare ◽  
Factors Associated ◽  
Risk Patients ◽  
Insight Into

Cardiovascular diseases result in millions of deaths around the globe annually, most of which are avoidable if identified early. Preventive healthcare has a major role in the fight against cardiovascular diseases. Primary, secondary, and tertiary prevention have their own applications along with benefits and drawbacks. This paper aims to elevate the sensitivity of “secondary prevention of cardiovascular diseases.” Firstly, it discusses common types of cardiovascular diseases around the globe and their causes. Secondly, it analyzes different risk factors associated with cardiovascular diseases and then discusses incoming technological trends in cardiovascular disease prediction and finally provides an insight into the importance of secondary prevention of cardiovascular diseases and commonly prescribed interventions for high risk patients.

scholarly journals SARS, MERS, COVID-19: Identification of Patients at a Higher Risk: A Narrative Review

2021 ◽  
Vol 2 (1) ◽  
pp. 57-70
Author(s):  
Hussein Noureldine ◽  
Georges Chedid ◽  
Jad Gerges Harb ◽  
Wared Nour-Eldine ◽  
Mariam Nour Eldine ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Cardiovascular Disease ◽  
High Risk ◽  
Pregnant Women ◽  
Early Identification ◽  
Factors Associated ◽  
High Risk Patients ◽  
Increased Risk ◽  
Risk Patients

The different presentations, comorbidities, and outcomes of COVID-19 highlight the importance of early identification and proper triage of patients. High-risk patients can be divided into patients with common comorbidities and patients with special categories. Common comorbidities include, but are not limited to, Cardiovascular Disease (CVD), Diabetes Mellitus (DM), immunosuppression, underlying respiratory disease, and obesity. Certain categories of COVID-19 patients are also at increased risk, including neonates and pregnant women.  In the present article, we delineate the reported risk factors for acquisition of infection, and for increased severity of the clinical disease. We also comparatively analyze those risk factors associated with COVID-19 and with the antecedent human acute respiratory syndrome-causing viruses, SARS-CoV-1 and MERS-CoV. We hypothesize that the structural similarities of the three viruses predict a similarity in the profile of high-risk patients. Several pathophysiological patterns have been detected to support this theory.

scholarly journals PARAMETERS OF ECG DISPERSION MAPPING AMONG STUDENTS OF NORTHERN UNIVERSITY

2019 ◽  
pp. 98-104 ◽  
Author(s):  
I. A Pogonysheva ◽  
D. A Pogonyshev ◽  
I. I Lunyak
Keyword(s):  
Risk Factors ◽  
Cardiovascular Diseases ◽  
High Risk ◽  
Questionnaire Survey ◽  
Cardiac Activity ◽  
State University ◽  
Men And Women ◽  
Factors Associated ◽  
Far North ◽  
Pathological Characteristics

The cardiac activity of students who have been born and live in the territory equated to regions of Far North was assessed. In total, 132 students of Nizhnevartovsk State University were examined using the CardioVisor-06c analyser that helps to diagnose dysfunctions of the cardiovascular system at preclinical level. The authors conducted a questionnaire survey to identify risk factors associated with cardiovascular diseases in students and analyzed the results of ECG dispersion mapping. The deterioration of the functional state of the myocardium was more pronounced among students with a high risk of developing cardiovascular diseases. The young men and women with pre-pathological characteristics of electrophysiological indicators were referred for additional examination and cardiology consultation.

scholarly journals Pre-existing Cardiovascular Disease in United States Population at High Risk for Severe COVID-19 Infection

2020 ◽  
Author(s):  
Adnan I Qureshi
Keyword(s):  
United States ◽  
Risk Factors ◽  
Cardiovascular Disease ◽  
At Risk ◽  
High Risk ◽  
Low Risk ◽  
Chronic Obstructive ◽  
Moderate Risk ◽  
High Risk Patients ◽  
Risk Patients

Background and Purpose There is increasing recognition of a relatively high burden of pre-existing cardiovascular disease in Corona Virus Disease 2019 (COVID 19) infected patients. We determined the burden of pre-existing cardiovascular disease in persons residing in United States (US) who are at risk for severe COVID-19 infection. Methods Age (60 years or greater), presence of chronic obstructive pulmonary disease, diabetes, mellitus, hypertension, and/or malignancy were used to identify persons at risk for admission to intensive care unit, or invasive ventilation, or death with COVID-19 infection. Persons were classified as low risk (no risk factors), moderate risk (1 risk factor), and high risk (two or more risk factors present) using nationally representative sample of US adults from National Health and Nutrition Examination Survey 2017 and 2018 survey. Results Among a total of 5856 participants, 2386 (40.7%) were considered low risk, 1325 (22.6%) moderate risk, and 2145 persons (36.6%) as high risk for severe COVID-19 infection. The proportion of patients who had pre-existing stroke increased from 0.6% to 10.5% in low risk patients to high risk patients (odds ratio [OR]19.9, 95% confidence interval [CI]11.6-34.3). The proportion of who had pre-existing myocardial infection (MI) increased from 0.4% to 10.4% in low risk patients to high risk patients (OR 30.6, 95% CI 15.7-59.8). Conclusions A large proportion of persons in US who are at risk for developing severe COVID 19 infection are expected to have pre-existing cardiovascular disease. Further studies need to identify whether targeted strategies towards cardiovascular diseases can reduce the mortality in COVID-19 infected patients.

scholarly journals Risk factors associated with secondary prevention of cardiovascular diseases

2018 ◽  
Vol 42 (4) ◽  
pp. 958-973
Author(s):  
Cléo Chinaia ◽  
Yára Juliano ◽  
Jane de Eston Armond ◽  
Patrícia Colombo Souza
Keyword(s):  
Risk Factors ◽  
Cardiovascular Diseases ◽  
Secondary Prevention ◽  
Factors Associated

scholarly journals Search for new pharmacological targets for increasing the efficiency of correction of cardiovascular diseases

2019 ◽  
Vol 5 (3) ◽  
pp. 67-77
Author(s):  
Liliya V. Korokina ◽  
Ivan V. Golubev ◽  
Olga N. Pokopejko ◽  
Anastasia V. Zagrebelnaya ◽  
Sergey A. Demchenko
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Cardiovascular Diseases ◽  
High Risk ◽  
Endothelial Dysfunction ◽  
New Targets ◽  
Pharmacological Targets ◽  
The World ◽  
Pharmacological Correction

Introduction: Cardiovascular disease (CVD) is the leading cause of death worldwide: no other reason causes as many deaths a year as CVD. An estimated 17.9 million people died of CVD in 2016, accounting for 31% of all deaths in the world. People with CVD or at high risk for these diseases (due to one or more risk factors, such as high blood pressure, diabetes, hyperlipidemia, or an already developed disease) need early detection and assistance through counseling and, if necessary, taking medication. Ways to find new targets for the correction of endothelium-associated pathology: The basis of the modern therapy for arterial hypertension and other cardiovascular diseases is the postulate of the need to correct endothelial dysfunction as an indication of the adequacy of antihypertensive and other types of treatment. Lowering blood pressure (BP) without normalizing endothelial function cannot be considered a successfully resolved clinical task. Currently, there are no drugs for specific pharmacological correction of endothelial dysfunction in cardiovascular diseases, and the search for new targets for pharmacological correction of endothelial dysfunction is one of the main tasks of pharmacology.

Sign in / Sign up

Export Citation Format

Share Document